Our findings showed that the plasma levels of individual biomarkers mSEPT9, IGFBP2, and DKK3 significantly differed between CRC cases and healthy controls for both early and advanced stages of CRC. The gene discussed is IGFBP2; the disease is colorectal carcinoma.